SE448302B - Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma - Google Patents

Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma

Info

Publication number
SE448302B
SE448302B SE8004792A SE8004792A SE448302B SE 448302 B SE448302 B SE 448302B SE 8004792 A SE8004792 A SE 8004792A SE 8004792 A SE8004792 A SE 8004792A SE 448302 B SE448302 B SE 448302B
Authority
SE
Sweden
Prior art keywords
group
hydrogen atom
symbol
formula
amino
Prior art date
Application number
SE8004792A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004792L (sv
Inventor
J Bouchaudon
D Farge
C James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE8004792L publication Critical patent/SE8004792L/
Publication of SE448302B publication Critical patent/SE448302B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8004792A 1979-06-29 1980-06-27 Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma SE448302B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7916845A FR2460290A1 (fr) 1979-06-29 1979-06-29 Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
SE8004792L SE8004792L (sv) 1980-12-30
SE448302B true SE448302B (sv) 1987-02-09

Family

ID=9227279

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004792A SE448302B (sv) 1979-06-29 1980-06-27 Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma

Country Status (16)

Country Link
US (1) US4742048A (xx)
JP (1) JPS5636440A (xx)
AU (1) AU544863B2 (xx)
BE (1) BE884077A (xx)
CH (1) CH651577A5 (xx)
DE (1) DE3024281A1 (xx)
DK (1) DK154940C (xx)
FR (1) FR2460290A1 (xx)
GB (1) GB2053231B (xx)
IE (1) IE51058B1 (xx)
IT (1) IT1131395B (xx)
LU (1) LU82567A1 (xx)
NL (1) NL8003762A (xx)
NZ (1) NZ194179A (xx)
SE (1) SE448302B (xx)
ZA (1) ZA803887B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4354966A (en) 1978-11-14 1982-10-19 Fujisawa Pharmaceutical Co., Ltd. Peptides, process for preparation thereof and use thereof
US4801580A (en) * 1978-11-14 1989-01-31 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4749691A (en) * 1978-11-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them
IE51684B1 (en) * 1980-10-27 1987-02-04 Fujisawa Pharmaceutical Co Peptides,process for their preparation and pharmaceutical compositions containing them
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
DK465681A (da) * 1980-11-11 1982-05-12 Fujisawa Pharmacetical Co Ltd Fremgangsmaade til fremstilling af peptidderivater
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
GR81332B (xx) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
US4493794A (en) * 1980-12-31 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
GR77929B (xx) 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co
JPH068312B2 (ja) * 1981-01-29 1994-02-02 藤沢薬品工業株式会社 新規ペプチドの製造法
US4399066A (en) 1981-01-29 1983-08-16 Fujisawa Pharmaceutical Co., Ltd. Novel peptide, process for preparation thereof and use thereof
GR79114B (xx) * 1981-01-29 1984-10-02 Fujisawa Pharmaceutical Co
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
HU205143B (en) * 1988-09-30 1992-03-30 Immunobiology Res Inst Inc Process for producing peptides having t cell suppressor activity and pharmaceutical compositions comprising same
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5312831A (en) * 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
JPH08510258A (ja) * 1993-05-14 1996-10-29 マリンクロット・メディカル・インコーポレイテッド ペプチド内へ導入するための配位子前駆体
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
EP0922958B1 (de) * 1997-12-11 2002-10-02 Roche Diagnostics GmbH Entstörung von diagnostischen Verfahren durch Peptide aus D-Aminosäuren
WO2001046127A1 (fr) * 1999-12-22 2001-06-28 Om Pharma Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise
EP3323424A1 (en) 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442889A1 (fr) * 1978-10-19 1980-06-27 Anvar Nouveaux composes hydrosolubles provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4335111A (en) * 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

Also Published As

Publication number Publication date
US4742048A (en) 1988-05-03
IE801342L (en) 1980-12-29
CH651577A5 (fr) 1985-09-30
NL8003762A (nl) 1980-12-31
IT8023072A0 (it) 1980-06-26
GB2053231A (en) 1981-02-04
NZ194179A (en) 1983-11-18
DK154940B (da) 1989-01-09
LU82567A1 (fr) 1981-02-03
GB2053231B (en) 1983-09-07
JPS5636440A (en) 1981-04-09
ZA803887B (en) 1981-07-29
DK277780A (da) 1980-12-30
JPH0159276B2 (xx) 1989-12-15
FR2460290B1 (xx) 1983-12-16
AU544863B2 (en) 1985-06-20
BE884077A (fr) 1980-12-29
DE3024281A1 (de) 1981-01-08
IT1131395B (it) 1986-06-18
SE8004792L (sv) 1980-12-30
DK154940C (da) 1989-05-29
IE51058B1 (en) 1986-09-17
AU5970080A (en) 1981-01-08
FR2460290A1 (fr) 1981-01-23

Similar Documents

Publication Publication Date Title
SE448302B (sv) Tetra- eller pentapeptider och faramceutiska kompositioner innehallande desamma
CA1065857A (en) Peptide derivatives of phosphonic and phosphinic acids
US3407203A (en) Novel process for the preparation of diketopiperazines
Ben-Ishai et al. Cleavage of N-carbobenzoxy groups by dry hydrogen bromide and hydrogen chloride
ZA941273B (en) Peptide compounds derived from boronic acid process for preparing them and pharmaceutical compositions containing them
DE69125939D1 (de) N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung
CA1250398A (fr) Tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
ES2257328T3 (es) Diazepanes sustituidos.
CA1267499A (en) Peptide amides and aldehydes
SE447389B (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet
CA2360275C (en) Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
WO1999000362A1 (en) Synthesis of aminocarbonyl substituted lactams
JPH01308297A (ja) テトラペプチド
CA1106361A (en) Peptide derivatives
Dahiya et al. First total synthesis and biological screening of hymenamide E
EP0020481A1 (en) Antibacterial peptide
CA1051874A (en) L-3-(3,4-dihydroxy-phenyl)-2-methylalanine-peptides
SE448462B (sv) Dipeptider och farmaceutiska kompositioner innehallande desamma
KR900003515B1 (ko) 헵타노일-glu-asp-ala-아미노산 면역자극물질
JP2006505555A5 (xx)
SE439772B (sv) Forfarande for framstellning av nya, substituerade fenylettiksyraamidforeningar och salter derav
Rancourt et al. Generation of glycinyl radicals via a 1, 5-hydrogen atom transfer reaction. Applications to γ-lactam formation
Kende et al. A useful synthesis of the Phe-Arg phosphinic acid dipeptide isostere
Schumann et al. Synthesis of different types of dipeptide building units containing N‐or C‐terminal arginine for the assembly of backbone cyclic peptides
GB1587427A (en) Polypeptide derivatives

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004792-1

Effective date: 19930109

Format of ref document f/p: F